4 Jefferies Group Replimune Group Trades
Jefferies Group acquired 714k Replimune Group shares worth $6.76M. That's 0.08% of their equity portfolio (206th largest holding). The first Replimune Group trade was made in Q1 2024. Since then Jefferies Group bought shares one more times and sold shares on two occasions. The stake costed the investor $6.09M, netting the investor a gain of 11% so far.
News about Replimune Group Inc and Jefferies Group
Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a...
Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a...
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a n...
Replimune: Continuing To Justify The Bear Thesis (For Now)
Replimune Group, Inc.''s stock falters amid uncertainties over approval of their oncolytic virus therapy, RP1, for melanoma treatment. Explore more details h...